Agios Pharmaceuticals, Inc.

Erste Asset Management GmbH AGIO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

2,804,900

Value ($000)

76,343

Weight

0.6%

2018 Q4 - 2025 Q4 (29 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	76,343	0.6%	2,804,900	12/31/2025
2025 Q3	11/12/2025	108,578	1.0%	2,764,900	9/30/2025
2025 Q2	8/14/2025	77,401	0.7%	2,326,489	6/30/2025
2025 Q1	5/14/2025	65,439	0.8%	2,229,900	3/31/2025
2024 Q4	2/10/2025	66,426	0.8%	2,009,900	12/31/2024
2024 Q3	11/14/2024	97,199	1.2%	2,184,900	9/30/2024
2024 Q2	11/26/2024	97,283	1.3%	2,254,900	6/30/2024
2024 Q1	11/26/2024	66,652	0.9%	2,279,900	3/31/2024
2023 Q4	11/26/2024	46,978	0.7%	2,107,900	12/31/2023
2023 Q3	11/26/2024	41,932	0.7%	1,694,200	9/30/2023
2023 Q2	11/26/2024	47,935	0.8%	1,694,200	6/30/2023
2023 Q1	11/26/2024	38,894	0.7%	1,694,200	3/31/2023
2022 Q4	11/26/2024	47,539	1.0%	1,694,200	12/31/2022
2022 Q3	11/26/2024	47,927	1.1%	1,694,200	9/30/2022
2022 Q2	11/26/2024	38,347	0.9%	1,729,200	6/30/2022
2022 Q1	11/25/2024	47,439	0.9%	1,629,200	3/31/2022
2021 Q4	11/25/2024	52,988	1.0%	1,578,200	12/31/2021
2021 Q3	11/25/2024	52,761	1.0%	1,143,200	9/30/2021
2021 Q2	11/25/2024	59,645	1.2%	1,083,900	6/30/2021
2021 Q1	11/25/2024	54,290	1.3%	1,053,900	3/31/2021
2020 Q4	11/25/2024	46,908	1.3%	1,053,900	12/31/2020
2020 Q3	11/25/2024	34,485	1.2%	987,500	9/30/2020
2020 Q2	11/22/2024	48,609	1.9%	910,100	6/30/2020
2020 Q1	11/22/2024	36,726	2.1%	1,035,400	3/31/2020
2019 Q4	11/22/2024	51,801	2.3%	1,078,700	12/31/2019
2019 Q3	11/22/2024	26,397	1.4%	810,700	9/30/2019
2019 Q2	11/22/2024	34,638	1.8%	694,700	6/30/2019
2019 Q1	11/22/2024	38,630	2.2%	574,700	3/31/2019
2018 Q4	11/26/2024	25,325	1.7%	559,600	12/31/2018